BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33147613)

  • 1. Impact of disease activity and treatments on ovarian reserve in patients with rheumatoid arthritis in the ESPOIR cohort.
    Valdeyron C; Soubrier M; Pereira B; Constantin A; Morel J; Gaudin P; Combe B; Gremeau AS; Dejou-Bouillet L; Pouly JL; Sapin V; Oris C; Brugnon F
    Rheumatology (Oxford); 2021 Apr; 60(4):1863-1870. PubMed ID: 33147613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ovarian reserve as measured by the anti-Müllerian hormone is not diminished in patients with rheumatoid arthritis compared to the healthy population.
    Lopez-Corbeto M; Martínez-Mateu S; Pluma A; Ferrer R; López-Lasanta M; De Agustín JJ; Barceló M; Julià A; Marsal S
    Clin Exp Rheumatol; 2021; 39(2):337-343. PubMed ID: 32896242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of serum anti-Müllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis.
    Brouwer J; Laven JS; Hazes JM; Schipper I; Dolhain RJ
    Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1534-8. PubMed ID: 23554429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between arthritis treatments and ovarian reserve: a prospective study.
    Alexander VM; Ashley-Martin J; Riley JK; Cooper AR; Ratts VS; Jungheim ES
    Reprod Biomed Online; 2021 Jun; 42(6):1203-1210. PubMed ID: 33931373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behçet's disease and spondyloarthritis on anti-Müllerian hormone levels.
    Henes M; Froeschlin J; Taran FA; Brucker S; Rall KK; Xenitidis T; Igney-Oertel A; Lawrenz B; Henes JC
    Rheumatology (Oxford); 2015 Sep; 54(9):1709-12. PubMed ID: 25957439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
    Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
    Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve.
    Di Mario C; Petricca L; Gigante MR; Barini A; Barini A; Varriano V; Paglionico A; Cattani P; Ferraccioli G; Tolusso B; Gremese E
    Endocrine; 2019 Feb; 63(2):369-375. PubMed ID: 30324323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Ovarian Reserve by Serum Anti-Müllerian Hormone in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.
    Zhang XH; Zhang YA; Chen X; Qiao PY; Zhang LY
    Int Arch Allergy Immunol; 2022; 183(4):462-469. PubMed ID: 34929705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs.
    Ozer Y; Yildiz M; Turan H; Tarcin G; Bingol Aydin D; Gunalp A; Haslak F; Kilic Konte E; Aslan E; Koker O; Bayramoglu E; Sahin S; Adrovic A; Barut K; Kasapcopur O; Evliyaoglu O
    Clin Rheumatol; 2024 Jan; 43(1):399-406. PubMed ID: 37646858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility and Ovarian Reserve among Women with Rheumatoid Arthritis.
    Eudy AM; McDaniel G; Hurd WW; Clowse MEB
    J Rheumatol; 2019 May; 46(5):455-459. PubMed ID: 30442826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Mullerian hormone: a prospective cohort study.
    Chen Y; Pei H; Chang Y; Chen M; Wang H; Xie H; Yao S
    J Ovarian Res; 2014 Nov; 7():108. PubMed ID: 25424986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values.
    Polyzos NP; Sakkas E; Vaiarelli A; Poppe K; Camus M; Tournaye H
    Hum Reprod; 2015 Jul; 30(7):1690-6. PubMed ID: 25948573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
    Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
    Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone exhibits a great variation in infertile women with different ovarian reserve patterns.
    Gorkem U; Kucukler FK; Togrul C; Gungor T
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):464-468. PubMed ID: 28419409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
    Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
    Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis.
    Luo W; Mao P; Zhang L; Chen X; Yang Z
    Ann Palliat Med; 2020 Mar; 9(2):207-215. PubMed ID: 32156138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
    Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
    J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?
    de Araujo DB; Yamakami LY; Aikawa NE; Bonfá E; Viana VS; Pasoto SG; Pereira RM; Serafin PC; Borba EF; Silva CA
    Scand J Rheumatol; 2014; 43(6):503-11. PubMed ID: 24881927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.